North America Deep Brain Simulation Market could be worth US$ 282.86 million by 2030,says Business Market Insights

The North America deep brain simulation market is expected to grow from US$ 282.86 million in 2022 to US$ 549.78 million by 2030. It is estimated to grow at a CAGR of 8.7% from 2022 to 2030. Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson's Disease, Tremor, Dystonia, Epilepsy, Alzheimer's Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)

Get PDF Sample Report + All Related Table and Graphs @: https://www.businessmarketinsights.com/sample/BMIRE00029026?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: North America Deep Brain Simulation Market:
The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson's disease, Alzheimer's disease, and dystonia are among the most common neurological disorders affecting older people. According to the National Institutes of Health (NIH), 8.5% of the world's population (i.e., around 617 million people) are 65 and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. The Canadian Psychological Association states that about 2% of the population suffers from obsessive-compulsive disorder (OCD). According to the World Health Organization (WHO), neurological diseases contribute 6.3% to the global disease burden and are one of the leading causes of death across the world. In addition, 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries are reported due to neurological diseases. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.

Abbott Laboratories
Boston Scientific Corp
Medtronic Plc
Newronika SpA
Bottom of Form

Chapter Details of North America Deep Brain Simulation Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: North America Deep Brain Simulation Market Landscape
Part 04: North America Deep Brain Simulation Market Sizing
Part 05: North America Deep Brain Simulation Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @https://www.businessmarketinsights.com/sample/BMIRE00029026?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sonam Patil

SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Bussiness Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.